AZTherapies, Inc. logo

AZTherapies, Inc.

AZTherapies is a privately held drug development company involved in the development & commercialization of drugs treating neuro degenerative disorders. AZTherapies is also developing disposable drug delivery devices for its own drugs.

The company, was founded in Israel in 2011 but later move to Boston; by David R. Elmaleh, an ass. prof. at Harvard Medical School. To encash the technology developed at Harvard Medical School Teaching Hospital under his guidance.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://aztherapies.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
222 Berkeley Street 12th Floor, MA 02116
Boston
United States
Email
Contact Number
+1 617 318 3411

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/aztherapies-inc-” connections=”true” suffix=””]

Drugs are based on technologies developed at The Massachusetts General Hospital, a Harvard Medical School Teaching Hospital. The science behind the technology is Blocking amyloid-beta peptide aggregation thus blockin AD progression.